This inventor holds 1 USPTO granted patent. Top assignee: General Electric Company. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Dinko Gonzalez Trotter: Innovator in Medical Imaging Technology
Introduction
Dinko Gonzalez Trotter is a notable inventor based in Clifton Park, NY (US). He has made significant contributions to the field of medical imaging technology. His innovative work focuses on the automatic characterization of malignancies, which has the potential to enhance diagnostic accuracy in clinical settings.
Latest Patents
Dinko holds a patent for a "Method and apparatus for automatically characterizing a malignancy." This invention involves the automatic evaluation of a region of interest based on assessments of various characteristics. The evaluation utilizes multiple image data sets acquired from different imaging modalities. In particular, the invention combines structural image data, such as CT scans, with functional image data, like PET scans, to improve the detection of lesions. The evaluation can be performed through automated routines or visual inspections by clinicians.
Career Highlights
Dinko is currently associated with General Electric Company, where he applies his expertise in medical imaging. His work is instrumental in advancing technologies that aid in the early detection and characterization of cancerous lesions. His innovative approach has the potential to transform how malignancies are evaluated in medical practice.
Collaborations
Dinko has collaborated with several professionals in his field, including Ricardo Scott Avila and Floribertus Heukensfeldt Jansen. These collaborations have contributed to the development and refinement of his patented technologies.
Conclusion
Dinko Gonzalez Trotter is a pioneering inventor whose work in medical imaging technology is making a significant impact on cancer diagnosis. His innovative methods and collaborations are paving the way for advancements in the evaluation of malignancies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
